Current clinical guidelines recommend implantable cardioverter-defibrillators (ICDs) in survivors of sudden cardiac arrest (SCA), except when the cause of the SCA is deemed reversible. But a new…

Continuous anticoagulation with apixaban during atrial fibrillation (AFib) ablation was found to be as safe as warfarin and other vitamin K antagonists (VKAs) in a randomized trial of 633 patients.

The trial, presented…

Higher alcohol consumption was linked to faster and faster heart rates in a study of more than 3,000 people attending the Munich Oktoberfest in Germany, according to research presented March 18 at the European Heart Rhythm Association (EHRA)…

A chest patch that records heartbeat patterns could potentially be a better detector of atrial fibrillation (AFib) and subsequently can expedite more timely treatment than traditional treatment, according to new research presented at the American…

The VEST study—an effort to reduce post-myocardial infarction (MI) mortality and one of ACC 18’s most anticipated clinical trials—failed to meet its primary endpoint of reducing sudden death due to ventricular arrhythmias, study leader Jeffrey…

Arthur J. Moss, MD, known in the cardiology field for his extensive research in diagnosing and treating long QT syndrome (LQTS), died of cancer Feb. 14 at his home in Brighton, New York. He was 86.

Moss’s work helped researchers identify…

The FDA announced on Feb. 26 a Class I recall for nine of Medtronic’s cardiac resynchronization therapy with defibrillation (CRT-D) devices and 12 of its…

The American Heart Association (AHA) believes an additional 50,000 lives per year could be saved if all hospitals in the United States adopted its Resuscitation Quality Improvement (RQI) program.

According to a…

The clinical benefit patients gain from remote monitoring with implantable electronic devices far outweighs the risk of the devices being hacked, according to a Feb. 20…

Longview Regional Medical Center in Texas co-hosted a “Play it Safe” event inviting teenagers across East Texas and surrounding areas to participate in free heart checkups. Now in its fifth year, the event was also hosted by Championship Hearts…

For nearly 6,000 patients with heart failure and chronic kidney disease (CKD), the use of an implantable cardioverter defibrillator (ICD) showed no mortality benefit but a higher risk of subsequent hospitalizations after covariate adjustment,…

Catheter ablation was associated with significantly fewer deaths and hospitalizations for worsening heart failure than medical therapy in a randomized trial of patients with atrial fibrillation (AFib) and heart failure.

All patients…

A pair of researchers at Utah State University are aiming to revolutionize the world of digital monitoring with a new technology that can measure a person’s heartbeat using nothing more than a video camera and specialized software, the university…

Four in ten cardiomyopathies are familial, suggesting an urgent need for more widespread genetic testing, a team of cardiologists …

In his 17 years as a dentist, Robert Camenzuli has seen allergic reactions, chest pains and seizures cycle through his office. But this January came with a first—a 53-year-old patient who went into cardiac arrest.

The patient, Alvin Uzee,…

Atrial fibrillation (AFib) patients face higher odds for short-term cancer diagnoses but, depending on how long they've had AFib, the could face lower odds for cancer in the long run, a January…

Nearly half of all out-of-hospital cardiac arrest (OHCA) survivors struggle to rejoin the workforce and participate in society post-heart attack, a study published in …

Asymptomatic atrial fibrillation (AFib) patients could be at a heightened risk for cardiac complications, especially if the condition is paroxysmal, a study published in CHEST reports.

AFib is often asymptomatic, lead author…

Artificial intelligence (AI)–assisted electrophysiology (EP) shows promise, but even its most ardent advocates aren’t ready for full-fledged endorsement—yet.   

AI revolution? 

A robot revolution is coming,…

The FDA issued a safety alert Jan. 17 for the Zoll LifeVest 4000, saying the external, wearable cardioverter defibrillator may fail to treat potentially fatal…

Roughly 1 in 4 children with Brugada syndrome treated with implantable cardioverter-defibrillators (ICDs) received life-saving shock therapy in a single-center study of 35 patients…